Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/norgestimate oral

Next Previous
Drug Profile

Ethinylestradiol/norgestimate oral

Alternative Names: Norgestimate/ethinyl estradiol; Ortho Tri-Cyclen; Ortho Tri-Cyclen Lo; Ortho-Prefest; Prefest

Latest Information Update: 24 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development; Ortho-McNeil Pharmaceutical
  • Developer Janssen Research & Development; Ortho-McNeil Pharmaceutical
  • Class Alkylated estrogenic steroids; Oral contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menopausal syndrome; Pregnancy

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Pregnancy (Prevention) (In volunteers) in Netherlands (PO, Tablet)
  • 01 Sep 2014 Janssen Research & Development completes a phase I trial in Contraception (In volunteers) in Netherlands (NCT02127593)
  • 13 May 2014 Janssen Research & Development plan a phase I bioequivalence trial in healthy women in Netherlands (NCT02127593)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top